Heather Millar

I haven’t written about cancer for about three months. That’s a long time for me.

The approach used in discussing palliative care can play a role in whether a patient seeks help.

Innovations in drug development, surgery, radiation and clinical trials have investigators hard at work in glioblastoma.

While there has been no hard evidence that exercise can improve survival in patients with cancer, it can boost patients' mood and how they feel.

Researchers are considering whether some smoldering myelomas warrant treatment and which regimens are best.

In pretreated multiple myeloma, experimental CAR-T cell immunotherapy offers the potential for long-term — and possibly even permanent — remission.

What happens if your doctor makes a medical mistake, and when is it appropriate to sue?

If an oncologist, infusion center nurse or any member of your medical team has asked you a question like that recently, you can thank Dr. Jimmie Holland, a pioneering psychiatrist who died Dec. 24 at the age of 89.

We want to accomplish something. We want to love and be loved. We want to explore, achieve, stand out. Yet we will all die someday.

If following a particular diet makes sense to you, and you can tolerate it, then by all means do so. But I beg you to remember that even unhealthy things won't kill you in moderation.

Newly approved CAR-T cell treatments inspire hope in patients with blood cancer.

Newer, less invasive tests are helping scientists isolate genomic alterations.

Researchers are identifying targets to treat chronic lymphocytic leukemia.

For some diagnosed with cancer, doing something radical can instill meaning and a sense of purpose.

Scientists are working to harness dogs’ ability to sniff out cancer.

CAR T-cell therapy is drastically changing the landscape of cancer treatment.

Cocktails of three, four or even five drugs of various classes are turning myeloma into a chronic condition.

By taking the brakes off immune response, immunotherapy empowers the body to fight resistant or recurrent classical Hodgkin lymphoma.

Why is the development of vitiligo a predictor of good response in patients taking immunotherapy for melanoma, and what can scientists learn from this?

Identified only a decade-and-a-half ago, GIST is already treatable with several targeted therapies, and scientists are researching more.

A study of acute lymphoblastic leukemia across the age spectrum is showing that some pediatric regimens can be successful in adults.

The characteristics of stage 3 lung cancer can vary widely, leaving patients and their doctors to wrestle with questions about how best to treat the disease.

In terms of both treatment and the emotional perspective of patients, metastatic breast cancer is different from other stages of the disease.

With new treatments transforming multiple myeloma into a chronic condition and additional therapies on the horizon, some experts believe a cure is within view.